Delivery Order SPE2DB22D6029-SPE2DB24FLSXG

Award Date 8/28/24
Potential Completion Date 8/29/24
Potential Value $1.5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $2,773.35, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of TETRACAINE 0.5% STERI-UNIT SOL 4ML, a medical product. It is a firm fixed-price delivery order contract with a completion date of February 3, 2025. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a...
This federal contract award, valued at $1,774.35, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of TETRACAINE 0.5% STERI-UNIT SOL 4ML, a medical product, with a completion date of February 4, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,364.96, is for the delivery of 4565555928 - Tetracain HCL 0.5% 12S, a medical product. The contract is a Firm Fixed Price Delivery Order with a completion date of September 20, 2024. This award is a part of AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, for the supply of Tetracaine 0.5% Steri-Unit Solution, a prescription medication. The contract is a delivery order with a firm fixed price of $1,052.91 and a completion date of May 29, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through December...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The order is for Tetracaine 0.5% Steri-Unit Solution 4mL, with a ceiling value of $5,253.61 and a completion date of February 1, 2024. The contract is a firm fixed-price delivery order and does not have any set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that holds a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The $1,221.13 firm fixed price delivery order is for the supply of the pharmaceutical product Piperacil-Tazobact 3.375 gm vials. The contract has an ultimate completion date of March 27, 2024 and was awarded on March 26, 2024, with no set-aside designation....
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of TOBREX 0.3% eye ointment 3.5 grams, valued at $1,929.74. The contract is a Delivery Order awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a defense agency, with a completion date of September 13, 2024. The contract is a Firm Fixed Price arrangement and does not utilize any set-aside designations. Amerisourcebergen is a major pharmaceutical distributor that holds...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division, a major supplier of pharmaceutical products and medical supplies to the U.S. government. The $82,456.40 firm fixed-price delivery order has a completion date of July 9, 2024. This contract is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA, valued at up to $999,999,999.00 through December 31, 2025....
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,223.59 firm-fixed-price delivery order covers the provision of a pharmaceutical product described as "4566758291 ! XDEMVY 0.25% DROP 10ML." The contract has an ultimate completion date of January 10, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract, valued at $12,857.85, is a firm fixed price delivery order for the supply of a pharmaceutical product, specifically "4563966574 ! VEVYE 0.1% EYE DROP 2ML." The contract has an ultimate completion date of March 15, 2024 and...
  • SPE2DB22D6029
    Indefinite Delivery Contract
  • SPE2DB22D6029-SPE2DB24FLSXG
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The $1,474.28 Firm Fixed Price Delivery Order contract is for the supply of Tetracaine 1% (20 mg/2 ml) vials. The contract has an ultimate completion date of August 29, 2024. Amerisourcebergen is a major pharmaceutical distributor that holds several Indefinite Delivery Contracts (IDCs) with the DLA and other federal agencies to provide a wide range of essential medical commodities, including prescription drugs, vaccines, and medical supplies, to support military treatment programs and facilities as well as other government healthcare providers. This specific award does not have a set-aside designation.

Generated 11/27/24, 9:36 AM